Identification of a novel gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant

PLoS Pathogens

Volumn 2, Issue 3, 2006, Pages 0211-0225

  Urisman, Anatoly ^a   Molinaro, Ross J ^b,c   Fischer, Nicole ^a   Plummer, Sarah J ^b   Casey, Graham ^b   Klein, Eric A ^b   Malathi, Krishnamurthy ^b   Magi Galluzzi, Cristina ^b   Tubbs, Raymond R ^b   Ganem, Don ^a,d   Silverman, Robert H ^b   DeRisi, Joseph L ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c CLEVELAND STATE UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; NUCLEIC ACID; OLIGONUCLEOTIDE; RIBONUCLEASE L; VIRUS PROTEIN; 2 5A DEPENDENT RIBONUCLEASE; 2-5A-DEPENDENT RIBONUCLEASE; RIBONUCLEASE; TUMOR MARKER; VIRUS DNA;

ANTIVIRAL ACTIVITY; ARTICLE; CARCINOGENESIS; CARCINOMA; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE EXACERBATION; DNA MICROARRAY; ENZYME ACTIVITY; FIBROBLAST; GENE FUNCTION; GENE SEQUENCE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HEMATOPOIETIC CELL; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; IN VIVO STUDY; INFECTION PREVENTION; MALE; MOLECULAR CLONING; NUCLEIC ACID ANALYSIS; NUCLEOTIDE SEQUENCE; PROSTATE TUMOR; PROTEIN ANALYSIS; RETROVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SAMPLE; STROMA CELL; TUMOR BIOPSY; VIRUS GENOME; VIRUS IDENTIFICATION; VIRUS INFECTION; WILD TYPE; XENOTROPIC MURINE LEUKEMIA RELATED VIRUS; ADENOCARCINOMA; AMINO ACID SEQUENCE; CLINICAL TRIAL; GENETIC PREDISPOSITION; GENETICS; HOMOZYGOTE; ISOLATION AND PURIFICATION; METABOLISM; MOLECULAR GENETICS; MULTICENTER STUDY; VIROLOGY;

GAMMARETROVIRUS; MURINAE; XENOTROPIC MURINE LEUKEMIA VIRUS;

ADENOCARCINOMA; AMINO ACID SEQUENCE; DNA, VIRAL; ENDORIBONUCLEASES; GAMMARETROVIRUS; GENETIC PREDISPOSITION TO DISEASE; GENOME, VIRAL; HOMOZYGOTE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 33645769298     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.0020025     Document Type: Article

References (82)

1. Kerr IM, Brown RE (1978) pppA2'p5'A2'p5'A: An inhibitor of protein synthesis synthesized with an enzyme fraction from interferon-treated cells. Proc Natl Acad Sci U S A 75: 256-260.
2. Zhou A, Hassel BA, Silverman RH (1993) Expression cloning of 2-5A-dependent RNAase: A uniquely regulated mediator of interferon action. Cell 72: 753-765.
3. Dong B, Silverman RH (1995) 2-5A-dependent RNase molecules dimerize during activation by 2-5A. J Biol Chem 270: 4133-4137.
4. Zhou A, Paranjape J, Brown TL, Nie H, Naik S, et al. (1997) Interferon action and apoptosis are defective in mice devoid of 29,59-oligoadenylate- dependent RNase L. EMBO J 16: 6355-6363.
5. Flodstrom-Tullberg M, Hultcrantz M, Stotland A, Maday A, Tsai D, et al. (2005) RNase L and double-stranded RNA-dependent protein kinase exert complementary roles in islet cell defense during coxsackievirus infection. J Immunol 174: 1171-1177.
6. Castelli JC, Hassel BA, Wood KA, Li XL, Amemiya K, et al. (1997) A study of the interferon antiviral mechanism: Apoptosis activation by the 2-5A system. J Exp Med 186: 967-972.
7. Li G, Xiang Y, Sabapathy K, Silverman RH (2004) An apoptotic signaling pathway in the interferon antiviral response mediated by RNase L and c-Jun NH2-terminal kinase. J Biol Chem 279: 1123-1131.
8. Malathi K, Paranjape JM, Ganapathi R, Silverman RH (2004) HPC1/RNASEL mediates apoptosis of prostate cancer cells treated with 2′,5′- oligoadenylates, topoisomerase I inhibitors, and tumor necrosis factor-related apoptosis-inducing ligand. Cancer Res 64: 9144-9151.
9. Xiang Y, Wang Z, Murakami J, Plummer S, Klein EA, et al. (2003) Effects of RNase L mutations associated with prostate cancer on apoptosis induced by 2′,5′-oligoadenylates. Cancer Res 63: 6795-6801.
10. Carpten J, Nupponen N, Isaacs S, Sood R, Robbins C, et al. (2002) Germline mutations in the ribonuclease L gene in families showing linkage with HPC1. Nat Genet 30: 181-184.
11. Casey G, Neville PJ, Plummer SJ, Xiang Y, Krumroy LM, et al. (2002) RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases. Nat Genet 32: 581-583.
12. Rennert H, Bercovich D, Hubert A, Abeliovich D, Rozovsky U, et al. (2002) A novel founder mutation in the RNASEL gene, 471delAAAG, is associated with prostate cancer in Ashkenazi Jews. Am J Hum Genet 71: 981-984.
13. Rokman A, Ikonen T, Seppala EH, Nupponen N, Autio V, et al. (2002) Germline alterations of the RNASEL gene, a candidate HPC1 gene at 1q25, in patients and families with prostate cancer. Am J Hum Genet 70: 1299-1304.
14. Nelson WG, De Marzo AM, Isaacs WB (2003) Prostate cancer. N Engl J Med 349: 366-381.
15. Carter BS, Bova GS, Beaty TH, Steinberg GD, Childs B, et al. (1993) Hereditary prostate cancer: Epidemiologic and clinical features. J Urol 150: 797-802.
16. Silverman RH (2003) Implications for RNase L in prostate cancer biology. Biochemistry 42: 1805-1812.
17. Downing SR, Hennessy KT, Abe M, Manola J, George DJ, et al. (2003) Mutations in ribonuclease L gene do not occur at a greater frequency in patients with familial prostate cancer compared with patients with sporadic prostate cancer. Clin Prostate Cancer 2: 177-180.
18. Wiklund F, Jonsson BA, Brookes AJ, Stromqvist L, Adolfsson J, et al. (2004) Genetic analysis of the RNASEL gene in hereditary, familial, and sporadic prostate cancer. Clin Cancer Res 10: 7150-7156.
19. Maier C, Haeusler J, Herkommer K, Vesovic Z, Hoegel J, et al. (2005) Mutation screening and association study of RNASEL as a prostate cancer susceptibility gene. Br J Cancer 92: 1159-1164.
20. Wang D, Coscoy L, Zylberberg M, Avila PC, Boushey HA, et al. (2002) Microarray-based detection and genotyping of viral pathogens. Proc Natl Acad Sci U S A 99: 15687-15692.
21. Wang D, Urisman A, Liu YT, Springer M, Ksiazek TG, et al. (2003) Viral discovery and sequence recovery using DNA microarrays. PLoS Biol 1: e2. DOI: 10.1371/journal.pbio.0000002
22. Urisman A, Fischer KF, Chiu CY, Kistler AL, Beck S, et al. (2005) E-Predict: A computational strategy for species identification based on observed DNA microarray hybridization patterns. Genome Biol 6: R78.
23. Clark SP, Mak TW (1983) Complete nucleotide sequence of an infectious clone of Friend spleen focus-forming provirus: gp55 is an envelope fusion glycoprotein. Proc Natl Acad Sci U S A 80: 5037-5041.
24. Raisch KP, Pizzato M, Sun HY, Takeuchi Y, Cashdollar LW, et al. (2003) Molecular cloning, complete sequence, and biological characterization of a xenotropic murine leukemia virus constitutively released from the human B-lymphoblastoid cell line DG-75. Virology 308: 83-91.
25. Wheeler DL, Church DM, Federhen S, Lash AE, Madden TL, et al. (2003) Database resources of the National Center for Biotechnology. Nucleic Acids Res 31: 28-33.
26. Wills NM, Gesteland RF, Atkins JF (1991) Evidence that a downstream pseudoknot is required for translational read-through of the Moloney murine leukemia virus gag stop codon. Proc Natl Acad Sci U S A 88: 6991-6995.
27. Herr W (1984) Nucleotide sequence of AKV murine leukemia virus. J Virol 49: 471-478.
28. O'Neill RR, Buckler CE, Theodore TS, Martin MA, Repaske R (1985) Envelope and long terminal repeat sequences of a cloned infectious NZB xenotropic murine leukemia virus. J Virol 53: 100-106.
29. Perryman S, Nishio J, Chesebro B (1991) Complete nucleotide sequence of Friend murine leukemia virus, strain FB29. Nucleic Acids Res 19: 6950.
30. Shinnick TM, Lerner RA, Sutcliffe JG (1981) Nucleotide sequence of Moloney murine leukaemia virus. Nature 293: 543-548.
31. Sijts EJ, Leupers CJ, Mengede EA, Loenen WA, van den Elsen PJ, et al. (1994) Cloning of the MCF1233 murine leukemia virus and identification of sequences involved in viral tropism, oncogenicity and T cell epitope formation. Virus Res 34: 339-349.
32. Antoine M, Wegmann B, Kiefer P (1998) Envelope and long terminal repeat sequences of an infectious murine leukemia virus from a human SCLC cell line: Implications for gene transfer. Virus Genes 17: 157-168.
33. Coffin JM, Hughes SH, Varmus HE (1997) Retroviruses. Cold Spring Harbor (New York): Cold Spring Harbor Laboratory Press. 843 p.
34. Battini JL, Heard JM, Danos O (1992) Receptor choice determinants in the envelope glycoproteins of amphotropic, xenotropic, and polytropic murine leukemia viruses. J Virol 66: 1468-1475.
35. Fass D, Davey RA, Hamson CA, Kim PS, Cunningham JM, et al. (1997) Structure of a murine leukemia virus receptor-binding glycoprotein at 2.0 angstrom resolution. Science 277: 1662-1666.
36. Tailor CS, Lavillette D, Marin M, Kabat D (2003) Cell surface receptors for gammaretroviruses. Curr Top Microbiol Immunol 281: 29-106.
37. Khan AS, Martin MA (1983) Endogenous murine leukemia proviral long terminal repeats contain a unique 190-base-pair insert. Proc Natl Acad Sci U S A 80: 2699-2703.
38. Battini JL, Rasko JE, Miller AD (1999) A human cell-surface receptor for xenotropic and polytropic murine leukemia viruses: Possible role in G protein-coupled signal transduction. Proc Natl Acad Sci U S A 96: 1385-1390.
39. Tailor CS, Nouri A, Lee CG, Kozak C, Kabat D (1999) Cloning and characterization of a cell surface receptor for xenotropic and polytropic murine leukemia viruses. Proc Natl Acad Sci U S A 96: 927-932.
40. Yang YL, Guo L, Xu S, Holland CA, Kitamura T, et al. (1999) Receptors for polytropic and xenotropic mouse leukaemia viruses encoded by a single gene at Rmc1. Nat Genet 21: 216-219.
41. Temin HM (1981) Structure, variation and synthesis of retrovirus long terminal repeat. Cell 27: 1-3.
42. Celander D, Hsu BL, Haseltine WA (1988) Regulatory elements within the murine leukemia virus enhancer regions mediate glucocorticoid responsiveness. J Virol 62: 1314-1322.
43. Speck NA, Baltimore D (1987) Six distinct nuclear factors interact with the 75-base-pair repeat of the Moloney murine leukemia virus enhancer. Mol Cell Biol 7: 1101-1110.
44. DeFranco D, Yamamoto KR (1986) Two different factors act separately or together to specify functionally distinct activities at a single transcriptional enhancer. Mol Cell Biol 6: 993-1001.
45. Miksicek R, Heber A, Schmid W, Danesch U, Posseckert G, et al. (1986) Glucocorticoid responsiveness of the transcriptional enhancer of Moloney murine sarcoma virus. Cell 46: 283-290.
46. Bruland T, Lavik LA, Dai HY, Dalen A (2003) A glucocorticoid response element in the LTR U3 region of Friend murine leukaemia virus variant FIS-2 enhances virus production in vitro and is a major determinant for sex differences in susceptibility to FIS-2 infection in vivo. J Gen Virol 84: 907-916.
47. Bruland T, Dai HY, Lavik LA, Kristiansen LI, Dalen A (2001) Gender-related differences in susceptibility, early virus dissemination and immunosuppression in mice infected with Friend murine leukaemia virus variant FIS-2. J Gen Virol 82: 1821-1827.
48. Thomas CY, Coppola MA, Holland CA, Massey AC (1990) Oncogenicity and U3 region sequences of class II recombinant MuLVs of CWD mice. Virology 176: 166-177.
49. Tomonaga K, Coffin JM (1999) Structures of endogenous nonecotropic murine leukemia virus (MLV) long terminal repeats in wild mice: Implication for evolution of MLVs. J Virol 73: 4327-4340.
50. Adam MA, Miller AD (1988) Identification of a signal in a murine retrovirus that is sufficient for packaging of nonretroviral RNA into virions. J Virol 62: 3802-3806.
51. Fisher J, Goff SP (1998) Mutational analysis of stem-loops in the RNA packaging signal of the Moloney murine leukemia virus. Virology 244: 133-145.
52. Berlioz C, Darlix JL (1995) An internal ribosomal entry mechanism promotes translation of murine leukemia virus gag polyprotein precursors. J Virol 69: 2214-2222.
53. Vagner S, Waysbort A, Marenda M, Gensac MC, Amalric F, et al. (1995) Alternative translation initiation of the Moloney murine leukemia virus mRNA controlled by internal ribosome entry involving the p57/PTB splicing factor. J Biol Chem 270: 20376-20383.
54. Prats AC, De Billy G, Wang P, Darlix JL (1989) CUG initiation codon used for the synthesis of a cell surface antigen coded by the murine leukemia virus. J Mol Biol 205: 363-372.
55. Fan H, Chute H, Chao E, Feuerman M (1983) Construction and characterization of Moloney murine leukemia virus mutants unable to synthesize glycosylated gag polyprotein. Proc Natl Acad Sci U S A 80: 5965-5969.
56. Schwartzberg P, Colicelli J, Goff SP (1983) Deletion mutants of Moloney murine leukemia virus which lack glycosylated gag protein are replication competent. J Virol 46: 538-546.
57. Chun R, Fan H (1994) Recovery of Glycosylated gag Virus from Mice Infected with a Glycosylated gag-Negative Mutant of Moloney Murine Leukemia Virus. J Biomed Sci 1: 218-223.
58. Corbin A, Prats AC, Darlix JL, Sitbon M (1994) A nonstructural gagencoded glycoprotein precursor is necessary for efficient spreading and pathogenesis of murine leukemia viruses. J Virol 68: 3857-3867.
59. Fujisawa R, McAtee FJ, Zirbel JH, Portis JL (1997) Characterization of glycosylated Gag expressed by a neurovirulent murine leukemia virus: Identification of differences in processing in vitro and in vivo. J Virol 71: 5355-5360.
60. Munk C, Prassolov V, Rodenburg M, Kalinin V, Lohler J, et al. (2003) 10A1-MuLV but not the related amphotropic 4070A MuLV is highly neurovirulent: Importance of sequences upstream of the structural Gag coding region. Virology 313: 44-55.
61. Portis JL, Fujisawa R, McAtee FJ (1996) The glycosylated gag protein of MuLV is a determinant of neuroinvasiveness: Analysis of second site revertants of a mutant MuLV lacking expression of this protein. Virology 226: 384-392.
62. Fujisawa R, McAtee FJ, Wehrly K, Portis JL (1998) The neuroinvasiveness of a murine retrovirus is influenced by a dileucine-containing sequence in the cytoplasmic tail of glycosylated Gag. J Virol 72: 5619-5625.
63. Bracho MA, Moya A, Barrio E (1998) Contribution of Taq polymerase-induced errors to the estimation of RNA virus diversity. J Gen Virol 79 (Part 12): 2921-2928.
64. Wernert N, Seitz G, Achtstatter T (1987) Immunohistochemical investigation of different cytokeratins and vimentin in the prostate from the fetal period up to adulthood and in prostate carcinoma. Pathol Res Pract 182: 617-626.
65. Chesebro B, Britt W, Evans L, Wehrly K, Nishio J, et al. (1983) Characterization of monoclonal antibodies reactive with murine leukemia viruses: Use in analysis of strains of friend MCF and Friend ecotropic murine leukemia virus. Virology 127: 134-148.
66. Tomonaga K, Coffin JM (1998) Structure and distribution of endogenous nonecotropic murine leukemia viruses in wild mice. J Virol 72: 8289-8300.
67. Albritton LM, Tseng L, Scadden D, Cunningham JM (1989) Aputative murine ecotropic retrovirus receptor gene encodes a multiple membrane-spanning protein and confers susceptibility to virus infection. Cell 57: 659-666.
68. Kim JW, Closs EI, Albritton LM, Cunningham JM (1991) Transport of cationic amino acids by the mouse ecotropic retrovirus receptor. Nature 352: 725-728.
69. Wang H, Kavanaugh MP, North RA, Kabat D (1991) Cell-surface receptor for ecotropic murine retroviruses is a basic amino-acid transporter. Nature 352: 729-731.
70. Gifford R, Tristem M (2003) The evolution, distribution and diversity of endogenous retroviruses. Virus Genes 26: 291-315.
71. Tlsty TD, Hein PW (2001) Know thy neighbor: Stromal cells can contribute oncogenic signals. Curr Opin Genet Dev 11: 54-59.
72. Bhowmick NA, Neilson EG, Moses HL (2004) Stromal .broblasts in cancer initiation and progression. Nature 432: 332-337.
73. Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, Tlsty TD, et al. (1999) Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res 59: 5002-5011.
74. Eisen MB, Spellman PT, Brown PO, Botstein D (1998) Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 95: 14863-14868.
75. Saldanha AJ (2004) Java Treeview - Extensible visualization of microarray data. Bioinformatics 20: 3246-3248.
76. Gordon D, Abajian C, Green P (1998) Consed: A graphical tool for sequence finishing. Genome Res 8: 195-202.
77. Stoye JP, Coffin JM (1987) The four classes of endogenous murine leukemia virus: Structural relationships and potential for recombination. J Virol 61: 2659-2669.
78. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG (1997) The CLUSTAL_X windows interface: Flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 25: 4876-4882.
79. Jeanmougin F, Thompson JD, Gouy M, Higgins DG, Gibson TJ (1998) Multiple sequence alignment with Clustal X. Trends Biochem Sci 23: 403-405.
80. Kimura M (1980) A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J Mol Evol 16: 111-120.
81. Bray N, Dubchak I, Pachter L (2003) AVID: A global alignment program. Genome Res 13: 97-102.
82. Frazer KA, Pachter L,, Poliakov A,, Rubin EM,, Dubchak I (2004) VISTA: Computational tools for comparative genomics. Nucleic Acids Res 32: W273-W279.